PHASE I-II STUDY OF F17752 IN PATIENTS WITH ADVANCED SOLID TUMOURS

Trial Profile

PHASE I-II STUDY OF F17752 IN PATIENTS WITH ADVANCED SOLID TUMOURS

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 24 Sep 2015

At a glance

  • Drugs F 17752 (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions; First in man; Therapeutic Use
  • Sponsors Pierre Fabre
  • Most Recent Events

    • 24 Sep 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top